000			01893pam a2200325 a 4500
005			20250918140433.0
008			110419s2010 enka b 001 0 eng
020			_a9781849730167 (hbk.) _cRM680.44
020			_a1849730164 (hbk.)
039		9	_a201107281509 _bzainol _c201106100923 _drazalis _y04-19-2011 _zrazalis
040			_aUKM
060			_aQV38 _b.M588 2010 9
090			_aQV38.M588 2010 9
245	0	0	_aMetabolism, pharmacokinetics, and toxicity of functional groups : _bimpact of the building blocks of medicinal chemistry in ADMET / _cedited by Dennis A. Smith
260			_aCambridge, [England] : _bRoyal Society of Chemistry, _c2010
300			_axiv, 530 p. : _bill. ; _c25 cm.
490	1		_aRSC drug discovery series, _x2041-3203 ; _vno. 1
505	0		_aDrugs and their structural motifs -- ADMET for the medicinal chemist -- Carboxylic acids and their bioisosteres -- Primary, secondary, and tertiary amines and their isosteres -- Sulfonamide as an essential functional group in drug design -- Influence of aromatic rings on ADME properties of drugs -- Influence of heteroaromatic rings on ADME properties -- Peptidomimetics and peptides as drugs: motifs incorporated to enhance drug characteristics -- Pharmacokinetics and metabolism of compounds that mimic enzyme transition states -- Alcohols and phenols: absorption, distribution, metabolism, and excretion -- Future targets and chemistry and ADME needs
650		2	_aPharmacokinetics
650		2	_aChemistry, Pharmaceutical _xmethods
650		2	_aPharmaceutical Preparations _xmetabolism
700	1		_aSmith, Dennis A.
710	2		_aRoyal Society of Chemistry (Great Britain)
907			_a.b15005525 _b2019-11-12 _c2019-11-12
942			_c01 _n0 _kQV38.M588 2010 9
914			_avtls003462751
991			_aJabatan Farmasi, KKL
998			_ad _b2011-06-04 _cm _da _feng _genk _y0 _z.b15005525
999			_c485315 _d485315